Atlas company financials

BIO-RAD LABORATORIES, INC.

Standardized 18-year financial series for BIO-RAD LABORATORIES, INC., built from filing-derived source data and exposed in JSON, CSV, and XLSX so it can feed iterFact artifacts or analyst workflows without hand-entering the numbers.

United StatesCIK 0000012208FY2008 → FY2025

Open JSON Download CSV Download XLSX Quarterly JSON Summary JSON Filing index

Latest fiscal year

FY2025

Revenue

$2.6B

Adjusted EBITDA

—

Net result

$759.9M

Net financial debt

$671.9M

Latest source: FY2025 filing · published data snapshot generated April 26, 2026

Phase 2 summary

Latest quarter, TTM, and growth are now pre-computed for chat and templates.

Latest quarter revenue

$653M

TTM revenue

$2.5B

TTM free cash flow

—

Latest quarter net result

-$341.9M

Quarterly coverage: 50 periods · latest quarter FY2025-Q3 · TTM revenue growth -0.9%.

What this gives you

A proof-of-concept company data surface, not a dead PDF shelf.

The same standardized payload behind this page is exposed through downloadable CSV and XLSX files plus a stable JSON route. That makes it usable as a live input to iterFact templates, a spreadsheet handoff, or a future API surface without re-normalizing the source documents again.

Source audit

Official links first, raw iterFact payloads right next to them.

Official sources

SEC EDGAR companyfacts
comparative · bio-rad-laboratories-inc-fy2008 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2011-02-28 · Retrieved: 2026-04-26T11:50:00.950766+00:00
SEC EDGAR companyfacts
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · us gaap companyfacts · comparative · bio-rad-laboratories-inc-fy2009 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2012-02-29 · Retrieved: 2026-04-26T11:50:00.950766+00:00
SEC EDGAR companyfacts
us-gaap:AccountsReceivableNetCurrent · us gaap companyfacts · comparative · bio-rad-laboratories-inc-fy2011 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2013-03-18 · Retrieved: 2026-04-26T11:50:00.950766+00:00
SEC EDGAR companyfacts
primary · bio-rad-laboratories-inc-fy2013 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2014-03-18 · Retrieved: 2026-04-26T11:50:00.950766+00:00
SEC EDGAR companyfacts
primary · bio-rad-laboratories-inc-fy2014 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2015-03-02 · Retrieved: 2026-04-26T11:50:00.950766+00:00

Ten-year series

Headline company financials by fiscal year

Fiscal year	Revenue	Adj. EBITDA	EBIT	Net result	Op. cash flow	Capex	Net debt	Status
FY2008	2B	—	183M	90M	191M	—	—	comparative annual fact carried from later 10k · missing accounts receivable · missing adjusted ebitda · missing capex · missing current assets · missing current liabilities · missing free cash flow · missing inventory · missing net financial debt · missing total assets
FY2009	2B	—	231M	145M	325M	-68M	88M	comparative annual fact carried from later 10k · missing accounts receivable · missing adjusted ebitda
FY2010	2B	—	284M	185M	226M	-88M	556M	missing accounts receivable · missing adjusted ebitda
FY2011	2B	—	295M	178M	260M	-103M	158M	missing adjusted ebitda
FY2012	2B	—	257M	164M	279M	-152M	269M	missing adjusted ebitda
FY2013	2B	—	169M	78M	175M	-113M	104M	missing adjusted ebitda
FY2014	2B	—	150M	89M	273M	-121M	—	missing adjusted ebitda · missing net financial debt
FY2015	2B	—	167M	113M	186M	-112M	—	missing adjusted ebitda · missing net financial debt
FY2016	2B	—	53M	28M	216M	-141M	—	missing adjusted ebitda · missing net financial debt
FY2017	2B

Filing provenance